@NP	Effects	1
@NP	ensheathing cells	12
@NP	photochemically damaged spinal cord	48
@NP	Enrique VerduÂ	85
@NP	Guillermo GarcõÂa-AlõÂas	102
@NP	Joaquim ForeÂs	128
@NP	Graciela GudinÄo-Cabrera	144
@NP	,1,2	168
@NP	Vilma C.	173
@NP	Vilma	173
@NP	C.	179
@NP	MunÄetoÂ n ,1 Manuel Nieto-Sampedro1	182
@NP	MunÄetoÂ n	182
@NP	,1 Manuel Nieto-Sampedro1	192
@NP	Xavier NavarroCA Transplantation	222
@NP	olfactory ensheathing cells -LRB- OECs -RRB- into photochemically damaged rat	259
@NP	olfactory ensheathing cells -LRB- OECs -RRB-	259
@NP	olfactory ensheathing cells	259
@NP	OECs	288
@NP	photochemically damaged rat	299
@NP	spinal cord	327
@NP	astrocyte reactivity and parenchyma cavitation	350
@NP	astrocyte reactivity	350
@NP	parenchyma cavitation	375
@NP	The photochemical lesion performed at T12-L1	398
@NP	The photochemical lesion	398
@NP	T12-L1	436
@NP	severe damage	455
@NP	the spinal cord	472
@NP	the first 15 days postoperation	504
@NP	all rats	536
@NP	their hindlimbs	553
@NP	The maximal area and volume of the cystic cavities	602
@NP	The maximal area and volume	602
@NP	the cystic cavities	633
@NP	non-transplanted rats	688
@NP	signi	715
@NP	the T12-L1 lesion site	731
@NP	signi	759
@NP	T9-T10 and L4-L6 cord levels	775
@NP	The density of astrocytes in the grey matter	805
@NP	The density	805
@NP	astrocytes in the grey matter	820
@NP	astrocytes	820
@NP	the grey matter	834
@NP	T12 ± L1 and L4-L6	865
@NP	T12 ± L1	865
@NP	L4-L6	876
@NP	non-transplanted and transplanted rats , but lower in the latter at T9-T10 level	885
@NP	non-transplanted and transplanted rats	885
@NP	non-transplanted	885
@NP	transplanted rats	906
@NP	lower in the latter at T9-T10 level	929
@NP	lower	929
@NP	the latter at T9-T10 level	938
@NP	the latter	938
@NP	T9-T10 level	952
@NP	non-transplanted rats	978
@NP	all astrocytes	1000
@NP	a hypertrophied appearance	1022
@NP	long and robust processes heavily GFAPpositive	1055
@NP	long and robust processes	1055
@NP	overexpression of proteoglycan inhibitor of neuritogenesis	1107
@NP	overexpression	1107
@NP	proteoglycan inhibitor of neuritogenesis	1125
@NP	proteoglycan inhibitor	1125
@NP	neuritogenesis	1151
@NP	transplanted rats	1178
@NP	only a few astrocytes	1196
@NP	hypertrophy and the majority	1225
@NP	hypertrophy	1225
@NP	the majority	1241
@NP	short , thin processes	1258
@NP	These results	1281
@NP	OECs	1309
@NP	damaged adult rat	1332
@NP	spinal cord	1350
@NP	a neuroprotective role	1368
@NP	astrocytic gliosis and cystic cavitation	1403
@NP	astrocytic gliosis	1403
@NP	cystic cavitation	1426
@NP	INTRODUCTION	1446
@NP	the adult CNS	1462
@NP	axonal regeneration following injury	1477
@NP	axonal regeneration	1477
@NP	injury	1507
@NP	¯	1519
@NP	both glial substrates and the extracellular matrix	1530
@NP	glial substrates	1535
@NP	the extracellular matrix	1556
@NP	lesions	1592
@NP	the gross morphology of the CNS	1611
@NP	the gross morphology	1611
@NP	the CNS	1635
@NP	transection , compression or photochemical injury	1652
@NP	transection	1652
@NP	compression	1665
@NP	photochemical injury	1680
@NP	astrocyte proliferation and reactivity	1702
@NP	astrocyte proliferation	1702
@NP	reactivity	1730
@NP	the establishment	1755
@NP	a glial scar	1776
@NP	a physical and chemical barrier to axonal extension -LSB- 1 -RSB-	1801
@NP	a physical and chemical barrier	1801
@NP	axonal extension -LSB- 1 -RSB-	1836
@NP	axonal extension	1836
@NP	1 -RSB-	1854
@NP	Infusion of trophic factors and cell transplantation	1858
@NP	Infusion	1858
@NP	trophic factors and cell transplantation	1870
@NP	trophic factors	1870
@NP	cell transplantation	1890
@NP	neurons and glial cells	1912
@NP	neurons	1912
@NP	glial cells	1924
@NP	the main strategies for promoting axonal regeneration in the CNS	1941
@NP	the main strategies	1941
@NP	axonal regeneration	1975
@NP	the CNS	1998
@NP	olfactory ensheathing cells -LRB- OECs -RRB-	2017
@NP	olfactory ensheathing cells	2017
@NP	OECs	2046
@NP	axonal regeneration	2081
@NP	spinal cord -LSB- 2 ± 4 -RSB- and peripheral nerve -LSB- 5 -RSB-	2104
@NP	spinal cord	2104
@NP	2 ± 4 -RSB- and peripheral nerve -LSB- 5 -RSB-	2117
@NP	2 ± 4 -RSB- and peripheral nerve -LSB-	2117
@NP	OEC transplantation	2148
@NP	functional recovery	2177
@NP	lumbar rhizotomy -LSB- 6 -RSB- and spinal cord transection	2203
@NP	lumbar rhizotomy	2203
@NP	6 -RSB-	2221
@NP	spinal cord transection	2228
@NP	4 -RSB-	2253
@NP	a photosensitizing organic dye -LRB- Rose Bengal , erythrosin B -RRB-	2262
@NP	a photosensitizing organic	2262
@NP	Rose Bengal	2294
@NP	erythrosin B	2307
@NP	the spinal cord and irradiated	2338
@NP	the spinal cord	2338
@NP	irradiated	2358
@NP	a light beam of appropriate wavelength	2374
@NP	a light beam	2374
@NP	appropriate wavelength	2390
@NP	the light	2414
@NP	the	2439
@NP	free radical production	2460
@NP	This	2485
@NP	vascular endothelium dysfunction and platelet aggregation	2497
@NP	subsequent vascular occlusion	2560
@NP	edema and tissue necrosis -LSB- 7 ±	2591
@NP	edema and tissue necrosis	2591
@NP	7 ±	2618
@NP	the secondary response seen after traumatic spinal cord injury -LSB- 12 -RSB-	2636
@NP	the secondary response	2636
@NP	traumatic spinal cord injury -LSB- 12 -RSB-	2670
@NP	traumatic spinal cord injury	2670
@NP	12 -RSB-	2700
@NP	Cystic cavities	2705
@NP	the first 14 days	2739
@NP	photochemical injury	2763
@NP	17 months post-injury -LSB- 9,10 -RSB-	2801
@NP	17 months post-injury	2801
@NP	9,10 -RSB-	2824
@NP	Schwann cell -LRB- SC -RRB-	2831
@NP	Schwann cell	2831
@NP	SC	2845
@NP	photochemically damaged adult rat	2871
@NP	spinal cord	2905
@NP	axonal ingrowth	2925
@NP	14 days after implantation	2944
@NP	14 days	2944
@NP	implantation	2958
@NP	minimal astrocytic gliosis at the interface -LSB- 13 -RSB-	2976
@NP	minimal astrocytic gliosis	2976
@NP	the interface -LSB- 13 -RSB-	3006
@NP	the interface	3006
@NP	13 -RSB-	3021
@NP	These results	3026
@NP	SC transplantation into the injured spinal cord	3053
@NP	SC transplantation	3053
@NP	the injured spinal cord	3077
@NP	astrocytic gliosis	3112
@NP	axonal regeneration	3143
@NP	the beneficial effects of transplanted SCs	3173
@NP	the beneficial effects	3173
@NP	transplanted SCs	3199
@NP	the transplantation area	3234
@NP	astrocytes	3267
@NP	their migration	3286
@NP	comparison to SCs	3306
@NP	comparison	3306
@NP	SCs	3320
@NP	OECs	3325
@NP	similar neurotrophic and neurotropic factors	3338
@NP	long distances	3408
@NP	the CNS -LSB- 14 -RSB-	3426
@NP	the CNS	3426
@NP	14 -RSB-	3435
@NP	this study	3443
@NP	we	3454
@NP	the effects of OEC transplants	3471
@NP	the effects	3471
@NP	OEC transplants	3486
@NP	the astrocytic reaction and size	3505
@NP	the cystic cavities	3541
@NP	photochemical injury of the adult rat spinal cord	3574
@NP	photochemical injury	3574
@NP	the adult rat spinal cord	3598
@NP	MATERIALS AND METHODS Primary cultures	3626
@NP	MATERIALS AND METHODS	3626
@NP	MATERIALS	3626
@NP	METHODS	3640
@NP	OECs from adult -LRB- 2.5 months old -RRB- male Wistar rats	3668
@NP	OECs	3668
@NP	adult -LRB- 2.5 months old -RRB- male Wistar rats	3678
@NP	2.5 months	3685
@NP	PKH26 cell linker -LRB- Sigma , St Louis , MO -RRB-	3762
@NP	PKH26 cell linker	3762
@NP	Sigma	3781
@NP	St Louis	3788
@NP	MO	3798
@NP	detail	3837
@NP	15 -RSB-	3855
@NP	transplantation	3864
@NP	frozen cell vials	3881
@NP	37 °C	3914
@NP	three times	3927
@NP	centrifugation	3942
@NP	200xg , 7 min	3958
@NP	200xg	3958
@NP	7 min	3965
@NP	Dulbecco 's	3975
@NP	Eagle 's medium -LRB- DMEM -RRB-	3995
@NP	Eagle 's medium	3995
@NP	Eagle 's	3995
@NP	DMEM	4011
@NP	the pellet resuspended in the same medium	4022
@NP	the pellet	4022
@NP	the same medium	4048
@NP	The cells	4065
@NP	2 h of thawing	4100
@NP	2 h	4100
@NP	thawing	4107
@NP	Twenty female Sprague ± Dawley rats -LRB- 250-300 g -RRB-	4116
@NP	Twenty female Sprague ± Dawley rats	4116
@NP	250-300 g	4151
@NP	sodium pentobarbital	4185
@NP	50 mg/kg , i.p.	4207
@NP	50 mg/kg	4207
@NP	the back of the animal	4227
@NP	the back	4227
@NP	the animal	4239
@NP	povidone iodine	4282
@NP	The skin and muscles	4299
@NP	The skin	4299
@NP	muscles	4312
@NP	the spinal cord	4348
@NP	T12 ± L1	4379
@NP	an extensive dorsal laminectomy	4389
@NP	The dura	4422
@NP	local in ® ltration with bupivacaine -LRB- 0.5 % -RRB-	4443
@NP	local	4443
@NP	® ltration with bupivacaine -LRB- 0.5 % -RRB-	4451
@NP	® ltration	4451
@NP	bupivacaine -LRB- 0.5 % -RRB-	4466
@NP	bupivacaine	4466
@NP	0.5 %	4479
@NP	nociceptive input	4506
@NP	Rose Bengal -LRB- RB ; 1.5 % in saline ; Sigma -RRB-	4525
@NP	Rose Bengal	4525
@NP	RB ; 1.5 % in saline ; Sigma	4538
@NP	RB	4538
@NP	1.5 % in saline ; Sigma	4542
@NP	1.5 % in saline	4542
@NP	1.5 %	4542
@NP	saline	4550
@NP	Sigma	4558
@NP	the exposed spinal cord for 10 min	4589
@NP	the exposed spinal cord	4589
@NP	10 min	4617
@NP	The excess dye	4625
@NP	The excess	4625
@NP	a double saline rinse	4660
@NP	Illumination was performed by means of two optic fibers	4683
@NP	Illumination	4683
@NP	means of two optic fibers	4713
@NP	means	4713
@NP	two optic fibers	4722
@NP	10 mm	4750
@NP	the spinal cord	4761
@NP	16 -RSB-	4778
@NP	The fibers	4783
@NP	a cold light source	4812
@NP	a 150W halogen bulb -LRB- Raypa , Barcelona , Spain -RRB-	4846
@NP	a 150W halogen bulb	4846
@NP	Raypa	4867
@NP	Barcelona	4874
@NP	Spain	4885
@NP	Spinal cord	4893
@NP	maximal nominal power for 5 min	4924
@NP	maximal nominal power	4924
@NP	5 min	4950
@NP	Ten rats	4957
@NP	a bilateral injection of a suspension of OECs -LRB- 60 000 in 3 µl DMEM -RRB-	4980
@NP	a bilateral injection	4980
@NP	a suspension of OECs -LRB- 60 000 in 3 µl DMEM -RRB-	5005
@NP	a suspension	5005
@NP	OECs -LRB- 60 000 in 3 µl DMEM -RRB-	5021
@NP	OECs	5021
@NP	60 000 in 3 µl DMEM	5027
@NP	60 000	5027
@NP	3 µl DMEM	5037
@NP	each spinal cord level from T12	5053
@NP	each spinal cord level	5053
@NP	T12	5081
@NP	L1 -LRB- group RB5 + EC -RRB-	5088
@NP	L1	5088
@NP	group RB5 + EC	5092
@NP	group RB5	5092
@NP	EC	5102
@NP	The cell suspension	5107
@NP	a glass micropipette	5147
@NP	means	5171
@NP	20 ms	5189
@NP	pulses of 10 psi -LRB- Picospritzer II , General Valve , Fairfield , NJ -RRB-	5199
@NP	pulses	5199
@NP	10 psi -LRB- Picospritzer II , General Valve , Fairfield , NJ -RRB-	5209
@NP	10 psi	5209
@NP	Picospritzer II	5217
@NP	General Valve	5234
@NP	Fairfield , NJ	5249
@NP	6 -RSB-	5265
@NP	A control group -LRB- group RB5 -RRB-	5269
@NP	A control group	5269
@NP	group RB5	5286
@NP	10 non-transplanted rats	5311
@NP	the wound	5346
@NP	5-0 silk thread in the muscular plane	5373
@NP	5-0 silk thread	5373
@NP	the muscular plane	5392
@NP	the skin	5415
@NP	small clips	5440
@NP	The animals	5469
@NP	a warm environment	5494
@NP	full recovery	5519
@NP	amitriptyline -LRB- 150 µg / ml -RRB- in their drinking water	5548
@NP	amitriptyline -LRB- 150 µg / ml -RRB-	5548
@NP	amitriptyline	5548
@NP	150 µg	5563
@NP	ml	5571
@NP	their drinking water	5578
@NP	autotomy -LSB- 6 -RSB-	5610
@NP	autotomy	5610
@NP	6 -RSB-	5620
@NP	Functional tests	5624
@NP	operation and daily up to 15 days post-operation -LRB- dpo -RRB-	5663
@NP	operation	5663
@NP	15 days	5689
@NP	post-operation -LRB- dpo -RRB-	5697
@NP	Locomotor activity	5719
@NP	the open-field walking scoring system	5758
@NP	Cheng et al. -LSB- 17 -RSB- , which measures the locomotor ability over 15 min	5799
@NP	Cheng et al. -LSB-	5799
@NP	the locomotor ability over 15 min	5833
@NP	the locomotor ability	5833
@NP	15 min	5860
@NP	Nociceptive sensitivity	6415
@NP	light pricking with a needle on the plantar surface of both hindpaws	6453
@NP	light pricking	6453
@NP	a needle on the plantar surface of both hindpaws	6473
@NP	a needle	6473
@NP	the plantar surface of both hindpaws	6485
@NP	the plantar surface	6485
@NP	both hindpaws	6508
@NP	The normal response	6523
@NP	vocalization and withdrawal of the paw	6547
@NP	vocalization and withdrawal	6547
@NP	the paw	6578
@NP	the pinprick score assigned	6590
@NP	the pinprick score	6590
@NP	no response -LRB- 0 -RRB-	6630
@NP	no response	6630
@NP	0	6643
@NP	normal reaction -LRB- 2 -RRB-	6649
@NP	normal reaction	6649
@NP	2	6666
@NP	Fifteen days	6670
@NP	injury	6689
@NP	all animals	6697
@NP	4 % paraformaldehyde	6760
@NP	phosphate-buffered saline -LRB- PBS , 0.1 M , pH 7.4 -RRB-	6783
@NP	phosphate-buffered saline	6783
@NP	PBS	6810
@NP	0.1 M	6815
@NP	pH 7.4	6822
@NP	The spinal cords	6831
@NP	the same solution for 24 h	6871
@NP	the same solution	6871
@NP	24 h	6893
@NP	three blocks identified as T9-T10 , T12-L1 and L4	6915
@NP	three blocks	6915
@NP	T9-T10 , T12-L1 and L4	6942
@NP	± L6	6963
@NP	Blocks	6968
@NP	®	6984
@NP	Zamboni 's fixative solution for 24 h	6992
@NP	Zamboni 's fixative solution	6992
@NP	Zamboni 's	6992
@NP	24 h	7024
@NP	PBS	7052
@NP	20 % sucrose	7067
@NP	48C	7093
@NP	Spinal cord blocks	7098
@NP	a cryotome -LRB- Reichert -RRB-	7135
@NP	a cryotome	7135
@NP	Reichert	7147
@NP	Transverse sections -LRB- 100 µm -RRB-	7158
@NP	Transverse sections	7158
@NP	100 µm	7179
@NP	¯ oating in PBS with 0.3 % Triton X-100 -LRB- Fluka -RRB- and 1 %	7204
@NP	¯ oating	7204
@NP	PBS with 0.3 % Triton X-100 -LRB- Fluka -RRB- and 1 %	7215
@NP	PBS with 0.3 % Triton X-100 -LRB- Fluka -RRB-	7215
@NP	PBS	7215
@NP	0.3 % Triton X-100 -LRB- Fluka -RRB-	7224
@NP	0.3 % Triton X-100	7224
@NP	Fluka	7243
@NP	1 %	7254
@NP	NGS	7276
@NP	ICN Pharmaceuticals	7282
@NP	1 h	7307
@NP	rabbit antiserum	7330
@NP	glial fibrillary acidic protein -LRB- GFAP ; 1:200 , Chemicon -RRB-	7350
@NP	glial fibrillary acidic protein	7350
@NP	GFAP ; 1:200 , Chemicon	7383
@NP	GFAP	7383
@NP	1:200 , Chemicon	7389
@NP	1:200	7389
@NP	Chemicon	7396
@NP	overnight at 48C	7406
@NP	overnight	7406
@NP	48C	7419
@NP	mouse antiserum to proteoglycan	7433
@NP	mouse antiserum	7433
@NP	proteoglycan	7452
@NP	-LSB- 18 -RSB- -LRB- 3PE8 ; 1:400 -RRB- for 48 h at 48 °C	7465
@NP	-LSB- 18 -RSB- -LRB- 3PE8 ; 1:400 -RRB-	7465
@NP	-LSB- 18 -RSB-	7465
@NP	3PE8 ; 1:400	7471
@NP	3PE8	7471
@NP	1:400	7477
@NP	48 h at 48 °C	7488
@NP	48 h	7488
@NP	48 °C	7496
@NP	the sections	7517
@NP	48C	7558
@NP	Cy2	7567
@NP	Cy3-labelled donkey anti-rabbit	7575
@NP	anti-mouse immunoglobulin G -LRB- 1:200 , Jackson Immunoresearch -RRB-	7610
@NP	anti-mouse immunoglobulin G	7610
@NP	1:200	7639
@NP	Jackson Immunoresearch	7646
@NP	additional washes	7681
@NP	sections	7700
@NP	gelatin-coated slides	7725
@NP	ethanol	7762
@NP	dextropropoxyphene -LRB- DPX , Fluka -RRB-	7787
@NP	dextropropoxyphene	7787
@NP	DPX , Fluka	7807
@NP	DPX	7807
@NP	Fluka	7812
@NP	Samples	7820
@NP	an Olympus BX-40 microscope equipped for epi ¯ uorescence -LSB- 6 -RSB-	7846
@NP	an Olympus BX-40 microscope	7846
@NP	epi ¯ uorescence -LSB- 6 -RSB-	7887
@NP	epi ¯ uorescence	7887
@NP	6 -RSB-	7903
@NP	Low power magnification -LRB- 310 -RRB- images of spinal cord sections	7907
@NP	Low power magnification -LRB- 310 -RRB- images	7907
@NP	310	7932
@NP	spinal cord sections	7947
@NP	the aid	7984
@NP	a digital camera	7995
@NP	Olympus DP20	8013
@NP	the microscope	8039
@NP	NIH Image software	8073
@NP	The cross-sectional area of the cystic cavity	8093
@NP	The cross-sectional area	8093
@NP	the cystic cavity	8121
@NP	sections of the three blocks	8155
@NP	sections	8155
@NP	the three blocks	8167
@NP	The volume of the lesion cavity at each spinal cord level	8185
@NP	The volume	8185
@NP	the lesion cavity at each spinal cord level	8199
@NP	the lesion cavity	8199
@NP	each spinal cord level	8220
@NP	the shape of the lesion	8272
@NP	the shape	8272
@NP	the lesion	8285
@NP	cone	8318
@NP	V = L/3x -LRB- A + a + a9 -RRB- , where L is the length of the spinal cord block	8327
@NP	V = L/3x -LRB- A + a + a9 -RRB-	8327
@NP	V = L/3x	8327
@NP	A	8335
@NP	+ a + a9	8336
@NP	a	8337
@NP	a9	8339
@NP	L	8350
@NP	the length of the spinal cord block	8355
@NP	the length	8355
@NP	the spinal cord block	8369
@NP	A , a and a9	8395
@NP	A	8395
@NP	a and a9	8398
@NP	the maximal , minimum and intermediate areas	8411
@NP	the cystic cavities	8458
@NP	The density of astrocytes -LRB- cells/mm2 -RRB-	8493
@NP	The density	8493
@NP	astrocytes -LRB- cells/mm2 -RRB-	8508
@NP	astrocytes	8508
@NP	cells/mm2	8520
@NP	images	8551
@NP	spinal cord sections	8561
@NP	a confocal imaging system -LRB- Leica TCS-4D -RRB-	8597
@NP	a confocal imaging system	8597
@NP	Leica TCS-4D	8624
@NP	NIH Image software	8645
@NP	the cell bodies of GFAP-immunoreactive -LRB- - ir -RRB- astrocytes	8665
@NP	the cell bodies	8665
@NP	GFAP-immunoreactive -LRB- - ir -RRB- astrocytes	8684
@NP	- ir	8705
@NP	at least five sections per animal	8737
@NP	at least five sections	8737
@NP	animal	8764
@NP	spinal block in a 0.07 mm2 area of the grey matter -LSB- 19 -RSB-	8775
@NP	spinal block	8775
@NP	a 0.07 mm2 area of the grey matter -LSB- 19 -RSB-	8791
@NP	a 0.07 mm2 area	8791
@NP	the grey matter -LSB- 19 -RSB-	8809
@NP	the grey matter	8809
@NP	19 -RSB-	8826
@NP	The experimental protocols	8831
@NP	the recommendations of the European Union and the US Department of Health	8869
@NP	the recommendations of the European Union	8869
@NP	the recommendations	8869
@NP	the European Union	8892
@NP	the US Department of Health	8915
@NP	the US Department	8915
@NP	Health	8936
@NP	the care and use of laboratory animals	8947
@NP	the care and use	8947
@NP	laboratory animals	8967
@NP	the ethical committees of our Institutions	9007
@NP	the ethical committees	9007
@NP	our Institutions	9033
@NP	Functional and histological measurements	9051
@NP	a blind manner	9110
@NP	All results	9126
@NP	mean and SEM	9151
@NP	Statistical comparisons between control and transplanted groups	9165
@NP	Statistical comparisons	9165
@NP	control and transplanted groups	9197
@NP	control	9197
@NP	transplanted groups	9209
@NP	Kruskal ± Wallis and Mann ± Whitney U tests	9245
@NP	Differences	9286
@NP	signi FIcant at p	9314
@NP	signi FIcant	9314
@NP	p	9330
@NP	RESULTS Table 1 .	9339
@NP	RESULTS	9339
@NP	Table 1	9347
@NP	Immunohistochemical results	9356
@NP	transplanted -LRB- RB5 ‡ EC -RRB-	9389
@NP	transplanted	9389
@NP	RB5 ‡ EC	9403
@NP	RB5	9403
@NP	‡ EC	9406
@NP	non-transplanted -LRB- RB5 -RRB- spinal cords	9415
@NP	non-transplanted -LRB- RB5 -RRB-	9415
@NP	spinal cords	9438
@NP	Fig. 1 .	9453
@NP	Fig.	9453
@NP	1	9458
@NP	Spinal cord sections	9461
@NP	GFAP	9504
@NP	non-transplanted -LRB- a , c -RRB-	9514
@NP	non-transplanted	9514
@NP	a , c	9532
@NP	a	9532
@NP	c	9534
@NP	transplanted -LRB- b , d -RRB-	9541
@NP	transplanted	9541
@NP	rats	9560
@NP	the injured segments T12 - L1 -LRB- a , b -RRB-	9574
@NP	the injured segments T12	9574
@NP	L1	9600
@NP	a , b	9604
@NP	a	9604
@NP	b	9606
@NP	rostral segments T9-T10 -LRB- c , d -RRB- x25	9616
@NP	Fig. 2 .	9652
@NP	Fig.	9652
@NP	2	9657
@NP	Confocal images of astrocytes	9660
@NP	Confocal images	9660
@NP	astrocytes	9679
@NP	GFAP -LRB- a , c -RRB-	9713
@NP	GFAP	9713
@NP	a , c	9719
@NP	a	9719
@NP	c	9721
@NP	3PE8 -LRB- b , d -RRB- in the grey matter of non-transplanted -LRB- a , b -RRB-	9736
@NP	3PE8 -LRB- b , d -RRB-	9736
@NP	3PE8	9736
@NP	the grey matter of non-transplanted -LRB- a , b -RRB-	9750
@NP	the grey matter	9750
@NP	non-transplanted -LRB- a , b -RRB-	9769
@NP	non-transplanted	9769
@NP	a , b	9787
@NP	a	9787
@NP	b	9789
@NP	OEC transplanted -LRB- c , d -RRB- rats	9796
@NP	OEC	9796
@NP	-LRB- c , d -RRB- rats	9813
@NP	Note co-localization of GFAP and 3PE8	9826
@NP	Note co-localization	9826
@NP	GFAP and 3PE8	9850
@NP	the clear difference in size and processes	9869
@NP	the clear difference	9869
@NP	size and processes	9893
@NP	astrocytes	9920
@NP	non-transplanted and transplanted cords	9934
@NP	non-transplanted	9934
@NP	transplanted cords	9955
@NP	Bar	9975
@NP	25 µm	9979
@NP	Fig. 3 .	9987
@NP	Fig.	9987
@NP	3	9992
@NP	Confocal images	9995
@NP	spinal cord sections	10014
@NP	transplanted rats at T9 ± T10 -LRB- a , b -RRB- T12-L1 -LRB- c -RRB-	10040
@NP	transplanted rats	10040
@NP	T9 ± T10 -LRB- a , b -RRB- T12-L1 -LRB- c -RRB-	10061
@NP	T9 ± T10 -LRB- a , b -RRB- T12-L1	10061
@NP	T9 ± T10 -LRB- a , b -RRB-	10061
@NP	T9 ± T10	10061
@NP	a , b	10069
@NP	a	10069
@NP	b	10071
@NP	c	10082
@NP	L4-L6 -LRB- d -RRB-	10092
@NP	L4-L6	10092
@NP	d	10099
@NP	pre-labeled PKH26	10111
@NP	glial cells -LRB- white points -RRB-	10141
@NP	glial cells	10141
@NP	white points	10154
@NP	OECs	10169
@NP	white matter of the dorsal funiculus -LRB- a -RRB-	10190
@NP	white matter	10190
@NP	the dorsal funiculus -LRB- a -RRB-	10206
@NP	the dorsal funiculus	10206
@NP	the grey matter	10238
@NP	central canal -LRB- b -RRB- and around cystic cavities -LRB- c , d -RRB-	10259
@NP	central canal	10259
@NP	b	10274
@NP	around cystic cavities	10281
@NP	Bar	10311
@NP	100 µm	10315
@NP	the spinal cord lesion	10331
@NP	all rats	10354
@NP	normal gait -LRB- score 5 -RRB- and nociceptive responses -LRB- score 2 -RRB-	10370
@NP	normal gait -LRB- score 5 -RRB-	10370
@NP	normal gait	10370
@NP	score 5	10383
@NP	nociceptive responses -LRB- score 2 -RRB-	10396
@NP	nociceptive responses	10396
@NP	score 2	10419
@NP	the day following injury	10432
@NP	all the rats	10458
@NP	the hindpaws	10479
@NP	any response	10509
@NP	the paw	10537
@NP	7 dpo	10549
@NP	only two of the 10 rats in each group	10555
@NP	only two	10555
@NP	the 10 rats in each group	10567
@NP	the 10 rats	10567
@NP	each group	10582
@NP	mild responses	10600
@NP	open FIeld walking	10634
@NP	The score to pinprick	10654
@NP	The score	10654
@NP	pinprick	10667
@NP	0.33 ± 0.18 and 0.33 ± 0.16	10685
@NP	0.33 ± 0.18	10685
@NP	0.33 ±	10685
@NP	0.18	10690
@NP	0.33 ± 0.16	10699
@NP	0.33 ±	10699
@NP	0.16	10704
@NP	groups RB5 and RB5 + GE	10712
@NP	groups RB5 and RB5	10712
@NP	GE	10731
@NP	the mean score of open FIeld walking	10757
@NP	the mean score	10757
@NP	open FIeld walking	10775
@NP	0.11 ± 0.07	10798
@NP	both groups	10812
@NP	the second week	10832
@NP	slight spontaneous recovery	10849
@NP	15 dpo	10894
@NP	the mean values	10902
@NP	scores of 1.17 ± 0.23 and 1.28 ± 0.23	10931
@NP	scores of 1.17 ± 0.23	10931
@NP	scores	10931
@NP	1.17 ± 0.23	10941
@NP	1.28 ± 0.23	10955
@NP	1.28 ±	10955
@NP	0.23	10960
@NP	pinprick	10969
@NP	0.83 ± 0.31 and 0.72 ± 0.19	10983
@NP	0.83 ± 0.31	10983
@NP	0.72 ± 0.19	10997
@NP	open FIeld walking in non-transplanted and transplanted rats , respectively	11011
@NP	open FIeld	11011
@NP	non-transplanted and transplanted rats	11033
@NP	non-transplanted	11033
@NP	transplanted rats	11054
@NP	p > 0.05	11088
@NP	p	11088
@NP	> 0.05	11089
@NP	>	11089
@NP	0.05	11090
@NP	the last test	11100
@NP	FIve of 10 rats of both experimental groups	11115
@NP	FIve	11115
@NP	10 rats of both experimental groups	11123
@NP	10 rats	11123
@NP	both experimental groups	11134
@NP	positive responses	11166
@NP	movements	11217
@NP	spinal cord sections at T12-L1 of group RB5 rats	11231
@NP	spinal cord sections	11231
@NP	T12-L1 of group RB5 rats	11255
@NP	T12-L1	11255
@NP	group RB5 rats	11265
@NP	a cavity surrounded by GFAP-ir cells	11280
@NP	a cavity	11280
@NP	GFAP-ir cells	11303
@NP	the dorsal and dorsolateral funiculi and the grey matter	11340
@NP	the dorsal	11340
@NP	dorsolateral funiculi and the grey matter	11355
@NP	dorsolateral funiculi	11355
@NP	the grey matter	11381
@NP	the ventrolateral and ventromedial funiculi	11406
@NP	the ventrolateral	11406
@NP	ventromedial funiculi	11428
@NP	Fig. 1a	11466
@NP	The cavity	11476
@NP	several spinal segments	11516
@NP	sections taken at T9-T10 the cavity	11544
@NP	sections	11544
@NP	T9-T10 the cavity	11562
@NP	T9-T10	11562
@NP	the cavity	11569
@NP	the dorsal columns spreading to the central canal -LRB- Fig. 1c -RRB-	11596
@NP	the dorsal columns	11596
@NP	the central canal -LRB- Fig. 1c -RRB-	11628
@NP	the central canal	11628
@NP	Fig. 1c	11647
@NP	A similar pattern	11657
@NP	spinal cord sections of L4-L6	11688
@NP	spinal cord sections	11688
@NP	L4-L6	11712
@NP	transplanted rats -LRB- group RB5 + EC -RRB-	11722
@NP	transplanted rats	11722
@NP	group RB5 + EC	11741
@NP	group RB5	11741
@NP	EC	11751
@NP	a cavity involving the dorsal funiculus including the dorsal horns	11755
@NP	a cavity	11755
@NP	the dorsal funiculus including the dorsal horns	11774
@NP	the dorsal funiculus	11774
@NP	the dorsal horns	11805
@NP	sections of T12-L1 -LRB- Fig. 1b -RRB-	11838
@NP	sections	11838
@NP	T12-L1 -LRB- Fig. 1b -RRB-	11850
@NP	T12-L1	11850
@NP	Fig. 1b	11858
@NP	A small cavity	11868
@NP	sections	11895
@NP	T9-T10 and L4-L6 levels	11913
@NP	the dorsal funiculus -LRB- Fig. 1d -RRB-	11958
@NP	the dorsal funiculus	11958
@NP	Fig. 1d	11980
@NP	The maximal area	11990
@NP	the cystic cavity	12010
@NP	all spinal cord blocks and the calculated volume of the cavity	12040
@NP	all spinal cord blocks	12040
@NP	all spinal cord	12040
@NP	blocks	12056
@NP	the calculated volume of the cavity	12067
@NP	the calculated volume	12067
@NP	the cavity	12092
@NP	group RB5 + EC	12117
@NP	group RB5	12117
@NP	EC	12127
@NP	group RB5	12138
@NP	signiFIcant differences	12154
@NP	T9-T10 and L4-L6 levels for both parameters -LRB- Table 1 -RRB-	12187
@NP	T9-T10 and L4-L6 levels	12187
@NP	both parameters -LRB- Table 1 -RRB-	12215
@NP	both parameters	12215
@NP	Table 1	12232
@NP	The density	12242
@NP	astrocytes -LRB- GFAP-ir cells -RRB-	12257
@NP	astrocytes	12257
@NP	GFAP-ir cells	12269
@NP	the grey matter of preserved spinal cord areas	12287
@NP	the grey matter	12287
@NP	preserved spinal cord areas	12306
@NP	transplanted rats	12372
@NP	T12-L1 and L4-L6 levels	12393
@NP	T9-T10 in transplanted rats	12431
@NP	T9-T10	12431
@NP	transplanted rats	12441
@NP	Table 1	12460
@NP	spinal cord sections from rats of group RB5	12473
@NP	spinal cord sections	12473
@NP	rats of group RB5	12499
@NP	rats	12499
@NP	group RB5	12507
@NP	all astrocytes	12518
@NP	a hypertrophied appearance	12540
@NP	long and robust processes	12573
@NP	all directions	12612
@NP	GFAP and 3PE8 -LRB- Fig. 2a , b -RRB-	12651
@NP	GFAP and 3PE8	12651
@NP	Fig. 2a , b	12666
@NP	Fig. 2a	12666
@NP	b	12674
@NP	These reactive astrocytes	12678
@NP	dorsal	12721
@NP	ventral horns of the three spinal cord	12732
@NP	ventral horns	12732
@NP	the three spinal cord	12749
@NP	transplanted rats	12791
@NP	few astrocytes	12810
@NP	a hypertrophied appearance	12832
@NP	most	12864
@NP	intensely GFAP-stained cell bodies	12876
@NP	short and thin processes	12916
@NP	A similar appearance	12942
@NP	spinal cord sections	12981
@NP	proteoglycan -LRB- 3PE8 ; Fig. 2c , d -RRB-	13023
@NP	proteoglycan	13023
@NP	3PE8 ; Fig. 2c , d	13037
@NP	3PE8	13037
@NP	Fig. 2c , d	13043
@NP	Fig. 2c	13043
@NP	d	13051
@NP	Reactive hypertrophied astrocytes	13055
@NP	dorsal and ventral horns	13106
@NP	the lesion site	13134
@NP	very few reactive astrocytes	13155
@NP	rostral -LRB- T9-T10 -RRB- and caudal -LRB- L4-L6 -RRB- cord sections	13197
@NP	rostral -LRB- T9-T10 -RRB-	13197
@NP	rostral	13197
@NP	T9-T10	13206
@NP	caudal -LRB- L4-L6 -RRB- cord sections	13218
@NP	caudal	13218
@NP	L4-L6	13226
@NP	cord sections	13233
@NP	OECs pre-labeled with PKH26 , identified by their red ¯ uorescence ,	13248
@NP	OECs pre-labeled with PKH26	13248
@NP	OECs	13248
@NP	PKH26	13270
@NP	their red ¯ uorescence	13291
@NP	the necrotic dorsal cavity	13340
@NP	Fig. 3	13368
@NP	the grey matter	13380
@NP	the central canal	13401
@NP	the dorsal and ventral grey matter	13444
@NP	the dorsal	13444
@NP	ventral grey matter	13459
@NP	OECs	13480
@NP	sections at the T12-L1 levels	13507
@NP	sections	13507
@NP	the T12-L1 levels	13519
@NP	the grey than in the white matter of rostral and caudal spinal cord blocks	13544
@NP	the white matter of rostral	13561
@NP	the white matter	13561
@NP	rostral	13581
@NP	Fig. 3	13620
@NP	DISCUSSION	13630
@NP	The results of this study	13641
@NP	The results	13641
@NP	this study	13656
@NP	OECs	13677
@NP	photochemically damaged adult rat	13700
@NP	spinal cord	13734
@NP	a neuroprotective role	13752
@NP	astrocytic gliosis and cystic cavitation	13787
@NP	astrocytic gliosis	13787
@NP	cystic cavitation	13810
@NP	the ® rst 15 days postlesion	13835
@NP	® rst	13839
@NP	15 days	13844
@NP	spinal cords	13877
@NP	a lower cystic cavity volume	13897
@NP	astrocytic reactivity	13938
@NP	respect	13965
@NP	nontransplanted cords	13976
@NP	Anisomorphic lesions of the CNS , typically caused by mechanical trauma ,	13999
@NP	Anisomorphic lesions	13999
@NP	the CNS	14023
@NP	mechanical trauma	14052
@NP	the glia limitans and the blood ± brain barrier at the injury site	14079
@NP	the glia limitans	14079
@NP	the blood ± brain barrier at the injury site	14101
@NP	the blood ± brain barrier	14101
@NP	the injury site	14128
@NP	Vascular breakage and vasospasm	14145
@NP	Vascular breakage	14145
@NP	vasospasm	14167
@NP	ischemia , hypoxia and hypoglycemia	14183
@NP	invasion of the injury area	14233
@NP	invasion	14233
@NP	the injury area	14245
@NP	blood cells and serum proteins	14264
@NP	the first 48 h after anisomorphic injury	14303
@NP	the first 48 h	14303
@NP	anisomorphic injury	14324
@NP	edema	14345
@NP	grey and white matter	14354
@NP	uniform necrosis	14377
@NP	myelin degeneration	14398
@NP	blood-derived macrophages	14419
@NP	myelin and other cell debris	14463
@NP	the lesion site -LSB- 20 -RSB-	14508
@NP	the lesion site	14508
@NP	20 -RSB-	14525
@NP	Photochemical injury of the adult spinal cord	14530
@NP	Photochemical injury	14530
@NP	the adult spinal cord	14554
@NP	plasma extravasation	14583
@NP	1 h post-lesion	14607
@NP	48 h	14631
@NP	the tissue	14636
@NP	disintegrated tissue and increased intercellular space	14665
@NP	disintegrated tissue	14665
@NP	increased intercellular space	14690
@NP	GFAP-ir cells	14721
@NP	24 h post-lesion	14752
@NP	they	14774
@NP	the border of the cavities	14801
@NP	the border	14801
@NP	the cavities	14815
@NP	14 days post-injury -LSB- 11 -RSB-	14831
@NP	14 days post-injury	14831
@NP	11 -RSB-	14852
@NP	an ultrastructural study	14860
@NP	Bunge et al. -LSB- 10 -RSB-	14886
@NP	Bunge et al. -LSB-	14886
@NP	the lesion cavity perimeter	14921
@NP	axons	14950
@NP	They	15004
@NP	aggregates of organelles	15019
@NP	aggregates	15019
@NP	organelles	15033
@NP	various stages of deterioration	15047
@NP	various stages	15047
@NP	deterioration	15065
@NP	Macrophages	15080
@NP	2 days	15105
@NP	number in the lesion cavity	15134
@NP	number	15134
@NP	the lesion cavity	15144
@NP	5 days -LSB- 10 -RSB-	15165
@NP	5 days	15165
@NP	10 -RSB-	15173
@NP	All these	15178
@NP	® ndings	15188
@NP	the photochemically induced spinal cord injury	15222
@NP	the	15222
@NP	spinal cord injury	15250
@NP	a model of anisomorphic lesion	15290
@NP	a model	15290
@NP	anisomorphic lesion	15301
@NP	the method first described by Watson and coworkers -LSB- 7 -RSB-	15332
@NP	the method	15332
@NP	Watson and coworkers -LSB- 7 -RSB-	15362
@NP	Watson	15362
@NP	coworkers -LSB- 7 -RSB-	15373
@NP	coworkers	15373
@NP	7 -RSB-	15384
@NP	RB	15388
@NP	the tail vein over a 5 min period	15409
@NP	the tail vein	15409
@NP	a 5 min period	15428
@NP	a body concentration of 40 mg/kg	15452
@NP	a body concentration	15452
@NP	40 mg/kg	15476
@NP	the injection	15508
@NP	the spinal cord -LRB- at T8 -RRB-	15523
@NP	the spinal cord	15523
@NP	T8	15543
@NP	means of a xenon laser lamp that produced a green beam centered at 560 nm	15565
@NP	means	15565
@NP	a xenon laser lamp that produced a green beam centered at 560 nm	15574
@NP	a xenon laser lamp	15574
@NP	a green beam centered at 560 nm	15607
@NP	a green beam	15607
@NP	560 nm	15632
@NP	the spinal cord	15645
@NP	5 min	15680
@NP	histopathological examination	15687
@NP	ischemic necrosis	15726
@NP	all the white matter tracts	15754
@NP	the ventrolateral funiculi and the ventromedial tracts of the anterior funiculi	15789
@NP	the ventrolateral funiculi	15789
@NP	the ventromedial tracts of the anterior funiculi	15820
@NP	the ventromedial tracts	15820
@NP	the anterior funiculi	15847
@NP	This region	15870
@NP	areas of extensive demyelination	15892
@NP	areas	15892
@NP	extensive demyelination	15901
@NP	vacuoles interspersed among regions of normally appearing myelinated axons	15930
@NP	vacuoles	15930
@NP	regions of normally appearing myelinated axons	15958
@NP	regions	15958
@NP	myelinated axons	15988
@NP	these animals	16020
@NP	a neurological de ® cit of about 75 %	16041
@NP	a neurological de ® cit	16041
@NP	75 %	16072
@NP	1	16079
@NP	week	16081
@NP	this time	16090
@NP	there	16100
@NP	no response to pain	16110
@NP	no response	16110
@NP	pain	16125
@NP	the rats	16135
@NP	impaired motor function	16151
@NP	-LSB- 8 -RSB-	16175
@NP	These findings	16180
@NP	those	16210
@NP	the present study	16228
@NP	RB	16253
@NP	the spinal cord dorsal surface and irradiated	16281
@NP	the spinal cord dorsal surface	16281
@NP	irradiated	16316
@NP	cold light	16332
@NP	The abolished functional responses	16344
@NP	the first week post-lesion and the minimal spontaneous recovery	16391
@NP	the first week post-lesion	16391
@NP	the minimal spontaneous recovery	16422
@NP	15 dpo observed in the present study	16458
@NP	15 dpo	16458
@NP	the present study	16477
@NP	those	16510
@NP	severe contusion or complete spinal cord transection	16531
@NP	severe contusion	16531
@NP	complete spinal cord transection	16551
@NP	21 -RSB-	16585
@NP	such spinal cord lesions	16608
@NP	rats	16634
@NP	¯ accid paralysis that persists for 3 ± 7 days	16647
@NP	¯ accid paralysis	16647
@NP	3 ± 7 days	16682
@NP	3 ±	16682
@NP	7 days	16684
@NP	7 days and 6 weeks post-lesion	16700
@NP	7 days	16700
@NP	6 weeks post-lesion	16711
@NP	most rats	16732
@NP	only slight hindlimb	16750
@NP	joint movements -LSB- 21 -RSB-	16771
@NP	joint movements	16771
@NP	21 -RSB-	16788
@NP	Our functional results	16793
@NP	the method used in the present study	16829
@NP	the method	16829
@NP	the present study	16848
@NP	a severe model of spinal cord injury	16887
@NP	a severe model	16887
@NP	spinal cord injury	16905
@NP	Cystic cavitation	16925
@NP	an usual feature	16946
@NP	anisomorphic spinal cord lesions -LSB- 10,12,21 -RSB-	16966
@NP	anisomorphic spinal cord lesions	16966
@NP	10,12,21 -RSB-	17000
@NP	photochemical injury -LSB- 9-13 -RSB-	17021
@NP	photochemical injury	17021
@NP	9-13 -RSB-	17043
@NP	a light and electron microscopy study	17053
@NP	Bunge et al. -LSB- 10 -RSB-	17092
@NP	Bunge et al. -LSB-	17092
@NP	the first cystic cavities	17116
@NP	2 days	17145
@NP	spinal cord injury	17182
@NP	The area of cystic cavities	17202
@NP	The area	17202
@NP	cystic cavities	17214
@NP	the first 2 weeks postlesion	17247
@NP	56 days	17307
@NP	Evidence of axonal regrowth around the lesion	17328
@NP	Evidence	17328
@NP	axonal regrowth around the lesion	17340
@NP	axonal regrowth	17340
@NP	the lesion	17363
@NP	2 and 6 months	17392
@NP	a period when the lesion cavities diminished in size -LSB- 10,12 -RSB-	17408
@NP	a period	17408
@NP	the lesion cavities	17422
@NP	size -LSB- 10,12 -RSB-	17456
@NP	size	17456
@NP	10,12 -RSB-	17462
@NP	Spontaneous axonal regeneration for short distances	17470
@NP	Spontaneous axonal regeneration	17470
@NP	short distances	17506
@NP	spinal cord compression	17552
@NP	interest is that the regenerating axons circumvented the ¯	17580
@NP	interest	17580
@NP	the regenerating axons	17597
@NP	the ¯	17633
@NP	uid-filled cysts formed at the rostral and caudal borders	17638
@NP	uid-filled cysts	17638
@NP	the rostral and caudal borders	17665
@NP	the rostral	17665
@NP	caudal borders	17681
@NP	22 -RSB-	17697
@NP	These findings	17702
@NP	2 weeks post-lesion	17731
@NP	2 weeks	17731
@NP	a critical period for development of cystic cavities	17754
@NP	a critical period	17754
@NP	development of cystic cavities	17776
@NP	development	17776
@NP	cystic cavities	17791
@NP	regenerating axons	17812
@NP	the lesion site	17841
@NP	the size of lesion cavities	17869
@NP	the size	17869
@NP	lesion cavities	17881
@NP	The reduction	17909
@NP	volume of the cystic cavity found at 15 dpo in the OECs	17926
@NP	volume	17926
@NP	the cystic cavity found at 15 dpo in the OECs	17936
@NP	the cystic cavity	17936
@NP	15 dpo in the OECs	17963
@NP	15 dpo	17963
@NP	the OECs	17973
@NP	transplanted rats	17982
@NP	a clear indication of reduced damage	18003
@NP	a clear indication	18003
@NP	reduced damage	18025
@NP	thus protection to the spinal cord tissue	18044
@NP	thus protection	18044
@NP	the spinal cord tissue	18063
@NP	a better substrate	18102
@NP	eventual axonal regeneration	18125
@NP	the transplanted OECs	18166
@NP	a neuroprotective role	18196
@NP	the loss of neurons and glial cells	18229
@NP	the loss	18229
@NP	neurons and glial cells	18241
@NP	neurons	18241
@NP	glial cells	18253
@NP	Astrocytes	18266
@NP	response	18296
@NP	anisomorphic lesions of the CNS	18308
@NP	anisomorphic lesions	18308
@NP	the CNS	18332
@NP	Hallmarks of astrocyte reactivity	18341
@NP	Hallmarks	18341
@NP	astrocyte reactivity	18354
@NP	hypertrophy	18383
@NP	the cell body	18398
@NP	increased arborization	18413
@NP	processes and up-regulation	18439
@NP	intermediate filaments	18470
@NP	GFAP and vimentin -LSB- 23 -RSB-	18501
@NP	GFAP and vimentin	18501
@NP	23 -RSB-	18520
@NP	The most important cell type in CNS scars	18525
@NP	The most important cell type	18525
@NP	CNS scars	18557
@NP	the astrocyte	18570
@NP	additional contributions	18590
@NP	fibroblasts	18618
@NP	microglial cells	18631
@NP	macrophages	18649
@NP	connective tissue	18662
@NP	scar formation	18692
@NP	¯ ammatory cells -LSB- 20 -RSB-	18710
@NP	¯ ammatory cells	18710
@NP	20 -RSB-	18727
@NP	The glial scar surrounding cystic cavities in the CNS parenchyma	18732
@NP	The glial scar	18732
@NP	cystic cavities	18759
@NP	the CNS parenchyma	18778
@NP	all anisomorphic lesions	18818
@NP	the photochemically induced spinal cord lesion -LSB- 10,11 -RSB-	18854
@NP	the photochemically	18854
@NP	spinal cord lesion -LSB- 10,11 -RSB-	18882
@NP	spinal cord lesion	18882
@NP	10,11 -RSB-	18902
@NP	The end feet of hypertrophied astrocytes	18910
@NP	The end feet	18910
@NP	hypertrophied astrocytes	18926
@NP	multilayered interfaces	18956
@NP	necrotic and intact neural tissue -LSB- 10,20 -RSB-	18988
@NP	Reactive astrocytes	19031
@NP	chondroitin sulphate proteoglycans	19059
@NP	CS-PGs	19095
@NP	the glial scar -LSB- 24,25 -RSB-	19127
@NP	the glial scar	19127
@NP	24,25 -RSB-	19143
@NP	In vitro studies	19151
@NP	CS-PGs	19182
@NP	neurite outgrowth -LSB- 18,26 -RSB-	19201
@NP	neurite outgrowth	19201
@NP	18,26 -RSB-	19220
@NP	Lakatos et al. -LSB- 27 -RSB-	19238
@NP	Lakatos et al. -LSB-	19238
@NP	the number of astrocytes expressing CS-PGs	19272
@NP	the number	19272
@NP	astrocytes expressing CS-PGs	19286
@NP	astrocytes	19286
@NP	CS-PGs	19308
@NP	astrocytes	19334
@NP	SCs	19367
@NP	astrocytes	19384
@NP	OECs	19411
@NP	the present study	19420
@NP	we	19438
@NP	OECs	19461
@NP	the astrogliotic response	19490
@NP	The astrocytes	19517
@NP	spinal cord sections	19544
@NP	OECs	19570
@NP	transplanted rats	19575
@NP	lower immunoreactivity	19625
@NP	GFAP and CS-PGs	19651
@NP	non-transplanted animals	19675
@NP	transplanted OECs	19712
@NP	the neurite	19750
@NP	inhibitory factors associated with astrogliosis	19762
@NP	inhibitory factors	19762
@NP	astrogliosis	19797
@NP	Several studies	19811
@NP	transplanted OECs	19846
@NP	axonal regeneration	19872
@NP	the spinal cord -LSB- 2-4,6 -RSB-	19895
@NP	the spinal cord	19895
@NP	2-4,6 -RSB-	19912
@NP	Regeneration of corticospinal axons	19920
@NP	Regeneration	19920
@NP	corticospinal axons	19936
@NP	transplanted OECs in a focal lesion of the corticospinal tract	19979
@NP	transplanted OECs	19979
@NP	a focal lesion of the corticospinal tract	20000
@NP	a focal lesion	20000
@NP	the corticospinal tract	20018
@NP	The cut axons	20043
@NP	the axis of the corticospinal tract	20073
@NP	the axis	20073
@NP	the corticospinal tract	20085
@NP	single sprouts	20112
@NP	3 weeks	20137
@NP	the full length of the lesioned area	20169
@NP	the full length	20169
@NP	the lesioned area	20188
@NP	the caudal part of the host corticospinal tract -LSB- 3 -RSB-	20220
@NP	the caudal part	20220
@NP	the host corticospinal tract -LSB- 3 -RSB-	20239
@NP	the host corticospinal tract	20239
@NP	3 -RSB-	20269
@NP	Eight months	20273
@NP	the distal spinal cord stumps	20390
@NP	animals receiving OECs transplants -LSB- 4 -RSB-	20423
@NP	animals	20423
@NP	OECs transplants -LSB- 4 -RSB-	20441
@NP	OECs transplants	20441
@NP	4 -RSB-	20459
@NP	These findings	20463
@NP	the short term	20495
@NP	transplanted OECs	20511
@NP	an appropriate environment that later allows for effective axonal regeneration	20536
@NP	an appropriate environment	20536
@NP	effective axonal regeneration	20585
@NP	OECs	20616
@NP	a variety	20629
@NP	adhesion molecules and growth factors	20642
@NP	BDNF	20688
@NP	PDGF	20694
@NP	NGF	20700
@NP	neurotrophin 3 -LRB- NT-3 -RRB- and neurotrophin 4 -LRB- NT-4 -RRB-	20705
@NP	neurotrophin 3 -LRB- NT-3 -RRB-	20705
@NP	neurotrophin 3	20705
@NP	NT-3	20721
@NP	neurotrophin 4 -LRB- NT-4 -RRB-	20731
@NP	neurotrophin 4	20731
@NP	NT-4	20747
@NP	addition to neurotrophic factors	20757
@NP	addition	20757
@NP	neurotrophic factors	20769
@NP	OECs	20791
@NP	laminin	20804
@NP	L1	20813
@NP	fibronectin	20817
@NP	S100	20830
@NP	neuropeptide Y	20836
@NP	glial-derived nexin	20852
@NP	neural cell adhesion molecule -LRB- N-CAM -RRB-	20876
@NP	neural cell adhesion molecule	20876
@NP	N-CAM	20907
@NP	OECs	20915
@NP	the low-af ® nity NGF receptor -LRB- p75 -RRB- -LSB- 14 -RSB-	20952
@NP	the low-af ® nity NGF receptor -LRB- p75 -RRB-	20952
@NP	the low-af ® nity NGF receptor	20952
@NP	p75	20982
@NP	14 -RSB-	20988
@NP	Neurotrophins secreted by OECs	20993
@NP	Neurotrophins	20993
@NP	OECs	21019
@NP	neurons	21038
@NP	survival and axonal regeneration	21057
@NP	survival	21057
@NP	axonal regeneration	21070
@NP	glial cells	21118
@NP	secretion of higher quantities of neurotrophic factors	21140
@NP	secretion	21140
@NP	higher quantities of neurotrophic factors	21153
@NP	higher quantities	21153
@NP	neurotrophic factors	21174
@NP	their reactivity	21219
@NP	Reactive astrocytes and microglia	21237
@NP	tyrosine kinase receptors -LRB- trk-A , trk-B , trk-C -RRB-	21279
@NP	tyrosine kinase receptors	21279
@NP	trk-A , trk-B , trk-C	21306
@NP	BDNF , NGF , NT-3 and NT-4	21332
@NP	BDNF	21332
@NP	NGF	21338
@NP	NT-3	21343
@NP	NT-4	21352
@NP	these receptors	21367
@NP	their biochemical activity	21394
@NP	28,29 -RSB-	21422
@NP	OECs	21430
@NP	long distances	21455
@NP	the CNS -LSB- 3,4,15	21473
@NP	the CNS	21473
@NP	3,4,15	21482
@NP	their effects	21494
@NP	the site of transplantation	21530
@NP	the site	21530
@NP	transplantation	21542
@NP	the present study	21562
@NP	OECs transplanted at the injured T12 ± L1 spinal cord segments ,	21581
@NP	OECs	21581
@NP	the injured T12 ± L1	21602
@NP	spinal cord segments	21621
@NP	15 dpo in considerable numbers	21657
@NP	15 dpo	21657
@NP	considerable numbers	21667
@NP	T9 and L4	21691
@NP	they	21708
@NP	spite of the difference in strain between donor and host animals	21749
@NP	spite	21749
@NP	the difference in strain between donor and host animals	21758
@NP	the difference	21758
@NP	strain between donor and host animals	21776
@NP	strain	21776
@NP	donor and host animals	21791
@NP	cocultures of astrocytes and OECs	21821
@NP	cocultures	21821
@NP	astrocytes and OECs	21835
@NP	Lakatos and co-workers -LSB- 27 -RSB-	21856
@NP	Lakatos	21856
@NP	co-workers -LSB- 27 -RSB-	21868
@NP	co-workers	21868
@NP	27 -RSB-	21880
@NP	OECs	21903
@NP	astrocyte monolayers	21923
@NP	a three-dimensional astrocyte matrix	21964
@NP	they confront within the CNS parenchyma	22010
@NP	they	22010
@NP	the CNS parenchyma	22031
@NP	the glial scar	22056
@VP	of ensheathing cells transplanted into photochemically damaged spinal cord	9
@VP	diminished astrocyte reactivity and parenchyma cavitation	339
@VP	performed at T12-L1	423
@VP	dragged their hindlimbs and did not respond to pinprick	545
@VP	dragged their hindlimbs	545
@VP	did not respond to pinprick	573
@VP	respond to pinprick	581
@VP	to pinprick	589
@VP	pinprick	592
@VP	were lower in transplanted than in non-transplanted rats	653
@VP	® cantly at the T12-L1 lesion site	720
@VP	® cantly at T9-T10 and L4-L6 cord levels	764
@VP	showed hypertrophy and the majority had short , thin processes	1218
@VP	had short , thin processes	1254
@VP	reducing astrocytic gliosis and cystic cavitation	1394
@VP	is in ¯ uenced by both glial substrates and the extracellular matrix	1514
@VP	alter the gross morphology of the CNS	1605
@VP	can be a physical and chemical barrier to axonal extension -LSB- 1 -RSB-	1794
@VP	be a physical and chemical barrier to axonal extension -LSB- 1 -RSB-	1798
@VP	are the main strategies for promoting axonal regeneration in the CNS	1937
@VP	promoting axonal regeneration in the CNS	1965
@VP	dye	2289
@VP	is absorbed by the dye resulting in free radical production	2424
@VP	absorbed by the dye resulting in free radical production	2427
@VP	dye resulting in free radical production	2443
@VP	resulting in free radical production	2447
@VP	seen after traumatic spinal cord injury -LSB- 12 -RSB-	2659
@VP	are formed during the first 14 days after photochemical injury	2721
@VP	formed during the first 14 days after photochemical injury	2725
@VP	remain up to 17 months post-injury -LSB- 9,10 -RSB-	2788
@VP	grafts implanted into photochemically damaged adult rat	2849
@VP	implanted into photochemically damaged adult rat	2856
@VP	may reduce astrocytic gliosis and promote axonal regeneration	3101
@VP	reduce astrocytic gliosis and promote axonal regeneration	3105
@VP	reduce astrocytic gliosis	3105
@VP	promote axonal regeneration	3135
@VP	inhibit their migration	3278
@VP	secrete similar neurotrophic and neurotropic factors	3330
@VP	are able to migrate long distances in the CNS -LSB- 14 -RSB-	3388
@VP	to migrate long distances in the CNS -LSB- 14 -RSB-	3397
@VP	migrate long distances in the CNS -LSB- 14 -RSB-	3400
@VP	formed after photochemical injury of the adult rat spinal cord	3561
@VP	prepared	3723
@VP	immunopurified	3733
@VP	labeled with PKH26 cell linker -LRB- Sigma , St Louis , MO -RRB-	3749
@VP	stored frozen as described in detail elsewhere -LSB- 15 -RSB-	3807
@VP	frozen as described in detail elsewhere -LSB- 15 -RSB-	3814
@VP	described in detail	3824
@VP	-LSB- 15 -RSB-	3854
@VP	washed three times by centrifugation -LRB- 200xg , 7 min -RRB- in Dulbecco 's	3920
@VP	modified Eagle 's medium -LRB- DMEM -RRB-	3986
@VP	resuspended in the same medium	4033
@VP	were transplanted within 2 h of thawing	4075
@VP	transplanted within 2 h of thawing	4080
@VP	were anesthetized with sodium pentobarbital -LRB- 50 mg/kg , i.p. -RRB-	4162
@VP	was shaved and disinfected with povidone iodine	4250
@VP	shaved and disinfected with povidone iodine	4254
@VP	were cut longitudinally	4320
@VP	cut longitudinally	4325
@VP	was exposed at T12 ± L1 by an extensive dorsal laminectomy	4364
@VP	exposed at T12 ± L1 by an extensive dorsal laminectomy	4368
@VP	was cut	4431
@VP	cut	4435
@VP	was made to minimize nociceptive input	4485
@VP	made to minimize nociceptive input	4489
@VP	to minimize nociceptive input	4494
@VP	minimize nociceptive input	4497
@VP	was applied directly on the exposed spinal cord for 10 min	4565
@VP	applied directly on the exposed spinal cord for 10 min	4569
@VP	dye	4636
@VP	was then removed by a double saline rinse	4640
@VP	removed by a double saline rinse	4649
@VP	was performed by means of two optic fibers	4696
@VP	performed by means of two optic fibers	4700
@VP	positioned 10 mm above the spinal cord -LSB- 16 -RSB-	4739
@VP	equipped with a 150W halogen bulb -LRB- Raypa , Barcelona , Spain -RRB-	4832
@VP	was illuminated at maximal nominal power for 5 min	4905
@VP	illuminated at maximal nominal power for 5 min	4909
@VP	was formed by 10 non-transplanted rats	5297
@VP	formed by 10 non-transplanted rats	5301
@VP	was sutured with 5-0 silk thread in the muscular plane	5356
@VP	sutured with 5-0 silk thread in the muscular plane	5360
@VP	was closed with small clips and disinfected	5424
@VP	closed with small clips and disinfected	5428
@VP	closed with small clips	5428
@VP	disinfected	5456
@VP	were kept in a warm environment until full recovery	5481
@VP	kept in a warm environment until full recovery	5486
@VP	to prevent autotomy -LSB- 6 -RSB-	5599
@VP	prevent autotomy -LSB- 6 -RSB-	5602
@VP	measures the locomotor ability over 15 min	5824
@VP	tested by light pricking with a needle on the plantar surface of both hindpaws	6443
@VP	was vocalization and withdrawal of the paw	6543
@VP	assigned	6609
@VP	ranged from no response -LRB- 0 -RRB- to normal reaction -LRB- 2 -RRB-	6618
@VP	removed	6853
@VP	fixed in the same solution for 24 h	6862
@VP	divided into three blocks identified as T9-T10 , T12-L1 and L4	6902
@VP	identified as T9-T10 , T12-L1 and L4	6928
@VP	xed in Zamboni 's fixative solution for 24 h	6985
@VP	then cryoprotected in PBS containing 20 % sucrose	7030
@VP	containing 20 % sucrose	7056
@VP	stored at 48C	7083
@VP	were sectioned in a cryotome -LRB- Reichert -RRB-	7117
@VP	sectioned in a cryotome -LRB- Reichert -RRB-	7122
@VP	washing	7508
@VP	mounted on gelatin-coated slides	7714
@VP	dehydrated in ethanol	7748
@VP	mounted with dextropropoxyphene -LRB- DPX , Fluka -RRB-	7774
@VP	equipped for epi ¯ uorescence -LSB- 6 -RSB-	7874
@VP	attached to the microscope and analyzed using NIH Image software	8027
@VP	attached to the microscope	8027
@VP	analyzed using NIH Image software	8058
@VP	using NIH Image software	8067
@VP	was measured in sections of the three blocks	8139
@VP	measured in sections of the three blocks	8143
@VP	is the length of the spinal cord block	8352
@VP	are the maximal , minimum and intermediate areas	8407
@VP	collected with a confocal imaging system -LRB- Leica TCS-4D -RRB-	8582
@VP	Using NIH Image software	8639
@VP	were approved by the ethical committees of our Institutions	8990
@VP	approved by the ethical committees of our Institutions	8995
@VP	were performed in a blind manner	9092
@VP	performed in a blind manner	9097
@VP	are shown as mean and SEM	9138
@VP	shown as mean and SEM	9142
@VP	were made using Kruskal ± Wallis and Mann ± Whitney U tests	9229
@VP	made using Kruskal ± Wallis and Mann ± Whitney U tests	9234
@VP	using Kruskal ± Wallis and Mann ± Whitney U tests	9239
@VP	were considered signi FIcant at p < 0.05	9298
@VP	considered signi FIcant at p < 0.05	9303
@VP	transplanted -LRB- c , d -RRB- rats	9800
@VP	= 25 µm	9978
@VP	showing pre-labeled PKH26 ensheathing glial cells -LRB- white points -RRB-	10103
@VP	ensheathing glial cells -LRB- white points -RRB-	10129
@VP	= 100 µm	10314
@VP	dragged the hindpaws and did not show any response to pinpricking the paw	10471
@VP	dragged the hindpaws	10471
@VP	did not show any response to pinpricking the paw	10496
@VP	show any response to pinpricking the paw	10504
@VP	pinpricking the paw	10525
@VP	showed mild responses to pinprick and in open FIeld walking	10593
@VP	to pinprick	10615
@VP	pinprick	10618
@VP	was 0.11 ± 0.07 for both groups	10794
@VP	was observed	10877
@VP	observed	10881
@VP	increased to scores of 1.17 ± 0.23 and 1.28 ± 0.23 for pinprick	10918
@VP	walking in non-transplanted and transplanted rats , respectively	11022
@VP	showed positive responses to pinprick and hip and/or knee movements	11159
@VP	showed positive responses to pinprick and hip	11159
@VP	to pinprick and hip	11185
@VP	pinprick and hip	11188
@VP	pinprick	11188
@VP	hip	11201
@VP	knee movements	11212
@VP	surrounded by GFAP-ir cells	11289
@VP	affecting the dorsal and dorsolateral funiculi and the grey matter	11330
@VP	were preserved -LRB- Fig. 1a -RRB-	11450
@VP	preserved -LRB- Fig. 1a -RRB-	11455
@VP	extended longitudinally over several spinal segments	11487
@VP	taken at T9-T10 the cavity	11553
@VP	spreading to the central canal -LRB- Fig. 1c -RRB-	11615
@VP	was found in spinal cord sections of L4-L6	11675
@VP	found in spinal cord sections of L4-L6	11679
@VP	involving the dorsal funiculus including the dorsal horns	11764
@VP	was observed in sections of T12-L1 -LRB- Fig. 1b -RRB-	11822
@VP	observed in sections of T12-L1 -LRB- Fig. 1b -RRB-	11826
@VP	affecting the dorsal funiculus -LRB- Fig. 1d -RRB-	11948
@VP	measured in all spinal cord blocks and the calculated volume of the cavity	12028
@VP	found at T9-T10 and L4-L6 levels for both parameters -LRB- Table 1 -RRB-	12178
@VP	extending in all directions	12599
@VP	heavily stained for GFAP and 3PE8 -LRB- Fig. 2a , b -RRB-	12631
@VP	were observed in dorsal	12704
@VP	observed in dorsal	12709
@VP	blocks analyzed	12771
@VP	analyzed	12778
@VP	showed a hypertrophied appearance	12825
@VP	showed intensely GFAP-stained cell bodies with short and thin processes	12869
@VP	were stained against proteoglycan -LRB- 3PE8 ; Fig. 2c , d -RRB-	13002
@VP	stained against proteoglycan -LRB- 3PE8 ; Fig. 2c , d -RRB-	13007
@VP	were observed in dorsal and ventral horns at the lesion site	13089
@VP	observed in dorsal and ventral horns at the lesion site	13094
@VP	seen in rostral -LRB- T9-T10 -RRB- and caudal -LRB- L4-L6 -RRB- cord sections	13189
@VP	identified by their red ¯ uorescence	13277
@VP	also spread through the dorsal and ventral grey matter	13424
@VP	show that OECs transplanted into photochemically damaged adult rat	13667
@VP	transplanted into photochemically damaged adult rat	13682
@VP	Transplanted spinal cords	13864
@VP	showed a lower cystic cavity volume	13890
@VP	reduced astrocytic reactivity with respect to nontransplanted cords	13930
@VP	typically caused by mechanical trauma	14032
@VP	disrupt the glia limitans and the blood ± brain barrier at the injury site	14071
@VP	degenerating myelin and other cell debris	14450
@VP	are observed at the lesion site -LSB- 20 -RSB-	14492
@VP	observed at the lesion site -LSB- 20 -RSB-	14496
@VP	causes plasma extravasation at 1 h post-lesion	14576
@VP	is edematous with disintegrated tissue and increased intercellular space	14647
@VP	were observed at 24 h post-lesion	14735
@VP	observed at 24 h post-lesion	14740
@VP	were swollen and only partly encased in myelin	14956
@VP	contained aggregates of organelles in various stages of deterioration	15009
@VP	were rare at 2 days	15092
@VP	were increased in number in the lesion cavity by 5 days -LSB- 10 -RSB-	15116
@VP	increased in number in the lesion cavity by 5 days -LSB- 10 -RSB-	15121
@VP	photochemically induced spinal cord injury	15226
@VP	may be considered as a model of anisomorphic lesion	15269
@VP	be considered as a model of anisomorphic lesion	15273
@VP	considered as a model of anisomorphic lesion	15276
@VP	first described by Watson and coworkers -LSB- 7 -RSB-	15343
@VP	to yield a body concentration of 40 mg/kg	15443
@VP	yield a body concentration of 40 mg/kg	15446
@VP	produced a green beam centered at 560 nm	15598
@VP	centered at 560 nm	15620
@VP	was irradiated for 5 min	15661
@VP	irradiated for 5 min	15665
@VP	interspersed among regions of normally appearing myelinated axons	15939
@VP	normally appearing myelinated axons	15969
@VP	showed a neurological de ® cit of about 75 % at 1 week	16034
@VP	was no response to pain	16106
@VP	showed impaired motor function -LSB- 8 -RSB-	16144
@VP	observed in the present study	16465
@VP	exhibit ¯ accid paralysis that persists for 3 ± 7 days	16639
@VP	persists for 3 ± 7 days	16669
@VP	recover only slight hindlimb joint movements -LSB- 21 -RSB-	16742
@VP	used in the present study	16840
@VP	may be considered as a severe model of spinal cord injury	16866
@VP	be considered as a severe model of spinal cord injury	16870
@VP	considered as a severe model of spinal cord injury	16873
@VP	at 2 days after photochemically induced spinal cord injury	17142
@VP	increased during the first 2 weeks postlesion	17230
@VP	did not change later up to 56 days post-lesion	17280
@VP	change later up to 56 days post-lesion	17288
@VP	diminished in size -LSB- 10,12 -RSB-	17442
@VP	has also been described after spinal cord compression	17522
@VP	been described after spinal cord compression	17531
@VP	described after spinal cord compression	17536
@VP	is that the regenerating axons circumvented the ¯	17589
@VP	circumvented the ¯	17620
@VP	formed at the rostral and caudal borders	17655
@VP	-LSB- 22 -RSB-	17696
@VP	is a critical period for development of cystic cavities	17751
@VP	appear in the lesion site later , when the size of lesion cavities is reduced	17831
@VP	is reduced	17897
@VP	reduced	17900
@VP	found at 15 dpo in the OECs	17954
@VP	providing a better substrate for eventual axonal regeneration	18092
@VP	exerted a neuroprotective role , reducing the loss of neurons and glial cells	18188
@VP	reducing the loss of neurons and glial cells	18220
@VP	become reactive in response to anisomorphic lesions of the CNS	18277
@VP	-LSB- 20 -RSB-	18726
@VP	surrounding cystic cavities in the CNS parenchyma	18747
@VP	induced spinal cord lesion -LSB- 10,11 -RSB-	18874
@VP	are localized into the glial scar -LSB- 24,25 -RSB-	19108
@VP	indicate that CS-PGs can inhibit neurite outgrowth -LSB- 18,26 -RSB-	19168
@VP	can inhibit neurite outgrowth -LSB- 18,26 -RSB-	19189
@VP	inhibit neurite outgrowth -LSB- 18,26 -RSB-	19193
@VP	expressing CS-PGs	19297
@VP	were co-cultured with SCs	19345
@VP	co-cultured with SCs	19350
@VP	were grown with OECs	19395
@VP	grown with OECs	19400
@VP	found that in vivo , OECs are also able to reduce the astrogliotic response	19441
@VP	are also able to reduce the astrogliotic response	19466
@VP	to reduce the astrogliotic response	19480
@VP	reduce the astrogliotic response	19483
@VP	were less hypertrophied	19593
@VP	less hypertrophied	19598
@VP	had lower immunoreactivity to GFAP and CS-PGs than in non-transplanted animals	19621
@VP	were able to reduce the neurite inhibitory factors associated with astrogliosis	19730
@VP	to reduce the neurite inhibitory factors associated with astrogliosis	19740
@VP	reduce the neurite inhibitory factors associated with astrogliosis	19743
@VP	associated with astrogliosis	19781
@VP	promote axonal regeneration in the spinal cord -LSB- 2-4,6 -RSB-	19864
@VP	guided by transplanted OECs in a focal lesion of the corticospinal tract	19969
@VP	crossed the full length of the lesioned area	20161
@VP	reentered the caudal part of the host corticospinal tract -LSB- 3 -RSB-	20210
@VP	receiving OECs transplants -LSB- 4 -RSB-	20431
@VP	allows for effective axonal regeneration	20574
@VP	secreted by OECs	21007
@VP	interact with neurons to promote survival and axonal regeneration	21024
@VP	to promote survival and axonal regeneration	21046
@VP	promote survival and axonal regeneration	21049
@VP	to induce secretion of higher quantities of neurotrophic factors	21130
@VP	induce secretion of higher quantities of neurotrophic factors	21133
@VP	to reduce their reactivity	21209
@VP	reduce their reactivity	21212
@VP	express tyrosine kinase receptors -LRB- trk-A , trk-B , trk-C -RRB-	21271
@VP	modulating their biochemical activity -LSB- 28,29 -RSB-	21383
@VP	are able to migrate long distances in the CNS -LSB- 3,4,15	21435
@VP	to migrate long distances in the CNS -LSB- 3,4,15	21444
@VP	migrate long distances in the CNS -LSB- 3,4,15	21447
@VP	are not restricted to the site of transplantation	21508
@VP	transplanted at the injured T12 ± L1 spinal cord segments ,	21586
@VP	were found by 15 dpo in considerable numbers at T9 and L4	21643
@VP	found by 15 dpo in considerable numbers at T9 and L4	21648
@VP	Using cocultures of astrocytes and OECs	21815
@VP	confront within the CNS parenchyma	22015
